US EditionICMR Seeks Collaboration for Malaria Vaccine Production Through Tech Transfer
- The Indian Council of Medical Research has developed a malaria vaccine, AdFalciVax, to prevent plasmodium falciparum infection and reduce community transmission.
- ICMR has invited Expressions of Interest from organizations interested in technology transfer for producing this malaria vaccine.
- Pre-Clinical validation of the vaccine was done in collaboration with ICMR-NIMR and other ICMR institutes.
- ICMR-RMRCBB will provide guidance and technical support throughout the vaccine's production and development phases.
18 Articles
18 Articles
Among children, the number of malaria deaths increased by 14 per cent in 2020 and 2021 worldwide.
The Print
The Hindu Business LineICMR invites expression of interest for commercial production of advanced malaria vaccine
New Delhi, Jul 20 (PTI) The Regional Medical Research Centre in Bhubaneswar under the ICMR has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. The Indian Council of Medical Research (ICMR), Delhi, has invited expression of interest (EoI) from eligible organisations, companies and manufacturers enthusiastic about […]
ICMR Invites EoIs for Commercial Production of Advanced Malaria Vaccine
Get latest articles and stories on India at LatestLY. The Regional Medical Research Centre in Bhubaneswar, under the Indian Council of Medical Research (ICMR), has developed an advanced malaria vaccine that can prevent plasmodium falciparum infection in individuals and minimise community transmission. India News | ICMR Invites EoIs for Commercial Production of Advanced Malaria Vaccine.
New Delhi, 21 Jul (Latin Press) India develops a multistage malaria candidate vaccine, called AdFalciVax, the first indigenous recombinant chimeric to prevent infection with that deadly ailment, transcended today. The post India develops multistage malaria candidate vaccine first appeared on News Prensa Latina.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
To view factuality data please Upgrade to Premium
